Vienna, VA, United States of America

Xing-Xiang Li

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Cellex Corporation. Active years: 2011-2013.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xing-Xiang Li in Influenza Virus Detection

Introduction

Xing-Xiang Li is a notable inventor based in Vienna, VA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of influenza viruses. With a total of 2 patents to his name, his work has the potential to enhance public health responses to viral outbreaks.

Latest Patents

Li's latest patents focus on reagents and kits for the detection of influenza virus types A and B. The inventions relate to reagents and methods that enable simple, rapid, specific, and sensitive detection of these viruses. The reagents developed are N-acetylneuraminic acid-firefly luciferin conjugates, which can be cleaved by influenza virus neuraminidase, facilitating effective virus detection.

Career Highlights

Xing-Xiang Li is associated with Cellex Corporation, where he continues to innovate in the field of diagnostics. His work at the company underscores his commitment to advancing medical technology and improving health outcomes.

Collaborations

Li collaborates with Tianxin Wang, contributing to the development of innovative solutions in the medical field. Their partnership exemplifies the importance of teamwork in driving scientific advancements.

Conclusion

Xing-Xiang Li's contributions to influenza virus detection through his patents represent a significant advancement in medical diagnostics. His work not only showcases his expertise but also highlights the potential for innovation in public health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…